HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young Il Kim Selected Research

Cholesteatoma

1/2023Comparison of Endoplasmic Reticulum Stress Messenger Ribonucleic Acid Expression Between Chronic Otitis Media With and Without Cholesteatoma.
10/2020Comparison of Autophagy mRNA Expression between Chronic Otitis Media With and Without Cholesteatoma.
10/2019Expression of C-type lectin receptor mRNA in otitis media with effusion and chronic otitis media with and without cholesteatoma.
6/2017Expression of C-type lectin receptor mRNA in chronic otitis media with cholesteatoma.
5/2014Increased expression of Dec-205, Bcl-10, Tim-3, and Trem-1 mRNA in chronic otitis media with cholesteatoma.
2/2014Expression of pattern recognition receptors in cholesteatoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young Il Kim Research Topics

Disease

48Neoplasms (Cancer)
10/2023 - 07/2003
15Hepatocellular Carcinoma (Hepatoma)
01/2022 - 02/2006
13Otitis Media with Effusion
10/2019 - 12/2008
12Inflammation (Inflammations)
11/2023 - 06/2010
10Otitis Media
01/2023 - 12/2008
8Rectal Neoplasms (Rectal Cancer)
10/2023 - 12/2020
8Neoplasm Metastasis (Metastasis)
08/2023 - 10/2010
8Type 2 Diabetes Mellitus (MODY)
01/2022 - 06/2010
7Pain (Aches)
12/2023 - 08/2018
7Necrosis
10/2017 - 05/2007
6Cholesteatoma
01/2023 - 02/2014
6Stomach Neoplasms (Stomach Cancer)
06/2022 - 02/2009
6Body Weight (Weight, Body)
01/2021 - 10/2006
5Thyroid Neoplasms (Thyroid Cancer)
07/2023 - 07/2004
5Infections
06/2017 - 12/2008
5Porcine Reproductive and Respiratory Syndrome (PRRS)
08/2016 - 12/2010
4Leukemia
11/2023 - 07/2015
4Hearing Loss (Hearing Impairment)
01/2023 - 08/2018
4Liver Neoplasms (Liver Cancer)
05/2016 - 04/2011
3Hemorrhage
11/2023 - 07/2007
3Colorectal Neoplasms (Colorectal Cancer)
10/2023 - 11/2019
3Glioma (Gliomas)
04/2022 - 01/2016
3Hematoma
03/2022 - 04/2004
3Postoperative Pain
12/2021 - 07/2020
3Brain Neoplasms (Brain Tumor)
04/2021 - 04/2020
3Neck Pain (Cervicalgia)
01/2021 - 04/2019
3Breast Neoplasms (Breast Cancer)
07/2020 - 10/2010
3Anaplastic Thyroid Carcinoma
03/2019 - 03/2014
3Sinusitis
11/2016 - 11/2013
3Carcinoma (Carcinomatosis)
01/2016 - 08/2012
3Obesity
08/2014 - 10/2010
3Thrombosis (Thrombus)
12/2006 - 03/2006
2Colonic Neoplasms (Colon Cancer)
04/2024 - 02/2023
2Chronic Subdural Hematoma
11/2023 - 11/2023
2Wounds and Injuries (Trauma)
11/2023 - 12/2008
2Cardiovascular Diseases (Cardiovascular Disease)
11/2023 - 07/2002
2Papillary Thyroid Cancer
07/2023 - 05/2023
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2022 - 04/2020
2Melanoma (Melanoma, Malignant)
01/2022 - 01/2009
2Edema (Dropsy)
04/2020 - 09/2019
2Intervertebral Disc Displacement (Herniated Disc)
01/2020 - 08/2018
2Arthritis (Polyarthritis)
01/2020 - 01/2011
2Myalgia
01/2020 - 01/2020
2Sensorineural Hearing Loss
10/2019 - 08/2019

Drug/Important Bio-Agent (IBA)

23Messenger RNA (mRNA)IBA
01/2022 - 10/2006
9Pattern Recognition ReceptorsIBA
06/2017 - 12/2010
7Proteins (Proteins, Gene)FDA Link
11/2023 - 08/2012
7CytokinesIBA
09/2019 - 01/2011
6Doxorubicin (Adriamycin)FDA LinkGeneric
05/2016 - 12/2010
5Biomarkers (Surrogate Marker)IBA
01/2023 - 09/2013
5Therapeutic UsesIBA
01/2021 - 12/2008
5LipidsIBA
01/2021 - 09/2013
5Toll-Like Receptors (Toll-Like Receptor)IBA
03/2014 - 12/2008
5Iodized OilIBA
12/2013 - 10/2004
4Activins (Activin)IBA
11/2023 - 02/2009
4Metformin (Glucophage)FDA LinkGeneric
01/2022 - 10/2015
4PolydioxanoneIBA
01/2021 - 04/2019
4Aquaporins (Water Channels)IBA
08/2019 - 02/2016
4Ethiodized Oil (Ethiodol)FDA Link
01/2017 - 08/2009
4Contrast MediaIBA
01/2016 - 04/2004
4Immunoglobulin A (IgA)IBA
03/2014 - 09/2009
3Inhibins (Inhibin)IBA
01/2022 - 08/2012
3MagnesiumIBA
12/2021 - 02/2018
3EnzymesIBA
01/2021 - 01/2013
3Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 12/2010
3TeaIBA
01/2021 - 04/2019
3C-Type Lectins (C-Type Lectin)IBA
10/2019 - 11/2013
3Pioglitazone (Actos)FDA Link
09/2019 - 01/2010
3ThrombinFDA Link
10/2018 - 05/2014
3InterleukinsIBA
10/2017 - 10/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2015 - 09/2007
3Immunoglobulin M (IgM)IBA
03/2014 - 12/2010
3Immunoglobulin G (IgG)IBA
03/2014 - 12/2010
3InterferonsIBA
03/2014 - 01/2013
3NucleotidesIBA
03/2014 - 12/2010
3Nitric Oxide Synthase (NO Synthase)IBA
12/2013 - 01/2013
2Cadherins (E-Cadherin)IBA
07/2023 - 10/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2023 - 01/2021
2Dipeptidyl-Peptidase IV InhibitorsIBA
01/2022 - 01/2020
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 01/2010
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 07/2002
2Analgesics (Analgesic Drugs)IBA
12/2021 - 10/2019
2Temozolomide (Temodar)FDA LinkGeneric
04/2021 - 01/2020
2Anticonvulsants (Antiepileptic Drugs)IBA
04/2021 - 04/2020

Therapy/Procedure

17Therapeutics
01/2022 - 07/2007
11Radiotherapy
08/2022 - 07/2003
8Chemoradiotherapy
10/2023 - 01/2020
8Drug Therapy (Chemotherapy)
06/2022 - 03/2006
5Conservative Treatment
01/2021 - 03/2006
5Stents
09/2014 - 04/2006
4Neoadjuvant Therapy
01/2024 - 11/2019
4Electroacupuncture
09/2022 - 01/2019
3Adjuvant Chemotherapy
04/2024 - 06/2022
3Glycemic Control
04/2017 - 09/2013
2Length of Stay
12/2023 - 11/2021
2Moxibustion
09/2022 - 04/2020
2Ileostomy
01/2022 - 10/2021
2Physical Therapy Modalities (Physical Therapy Technique)
01/2021 - 08/2019
2Acupuncture Therapy
01/2020 - 08/2018
2Injections
10/2019 - 01/2016